camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics
https://ash.confex.com/ash/2022/webprogram/Paper157748.html
 
Jerzy Dyczkowski, PhD1*, Alex F. Herrera, MD2, Carmelo Carlo-Stella, MD, PhD3, Pier Luigi Zinzani, MD, PhD4, Marie Toukam, PhD5*, Hans G. Cruz, PhD1, Karin Havenith, PhD6*, Joseph Boni, PhD5*, Jens Wuerthner, MD, PhD1 and Serafino Pantano, PhD1*
 
Nov 4, 2022
 
Prev Next